TW353066B - Arylquinoline-carboxamide derivatives and pharmaceutical compositions containing them - Google Patents
Arylquinoline-carboxamide derivatives and pharmaceutical compositions containing themInfo
- Publication number
- TW353066B TW353066B TW085114500A TW85114500A TW353066B TW 353066 B TW353066 B TW 353066B TW 085114500 A TW085114500 A TW 085114500A TW 85114500 A TW85114500 A TW 85114500A TW 353066 B TW353066 B TW 353066B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- formula
- arylquinoline
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- -1 (2-carboxy)benzylcarbonyl Chemical group 0.000 abstract 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI002461 IT1276170B1 (it) | 1995-11-24 | 1995-11-24 | Derivati chinolinici |
| ITMI961689 IT1307331B1 (it) | 1996-08-02 | 1996-08-02 | Derivati chinolinici |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW353066B true TW353066B (en) | 1999-02-21 |
Family
ID=26331326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW085114500A TW353066B (en) | 1995-11-24 | 1996-11-23 | Arylquinoline-carboxamide derivatives and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6277862B1 (OSRAM) |
| EP (1) | EP0876347B1 (OSRAM) |
| JP (1) | JP2000501104A (OSRAM) |
| KR (1) | KR19990071597A (OSRAM) |
| CN (1) | CN1207730A (OSRAM) |
| AP (1) | AP9801237A0 (OSRAM) |
| AR (1) | AR004972A1 (OSRAM) |
| AT (1) | ATE289994T1 (OSRAM) |
| BG (1) | BG102558A (OSRAM) |
| BR (1) | BR9611820A (OSRAM) |
| CA (1) | CA2238298A1 (OSRAM) |
| CZ (1) | CZ157998A3 (OSRAM) |
| DE (1) | DE69634416T2 (OSRAM) |
| EA (1) | EA002124B1 (OSRAM) |
| ES (1) | ES2236757T3 (OSRAM) |
| IL (1) | IL124522A0 (OSRAM) |
| MX (1) | MX9804107A (OSRAM) |
| NO (1) | NO311212B1 (OSRAM) |
| NZ (1) | NZ323387A (OSRAM) |
| OA (1) | OA11010A (OSRAM) |
| PL (1) | PL326967A1 (OSRAM) |
| SK (1) | SK66798A3 (OSRAM) |
| TR (1) | TR199800924T2 (OSRAM) |
| TW (1) | TW353066B (OSRAM) |
| UY (1) | UY24733A1 (OSRAM) |
| WO (1) | WO1997021680A1 (OSRAM) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK44894A3 (en) * | 1991-10-18 | 1995-04-12 | Monsanto Co | Trisubstituted aromatic compounds, method of their preparation and fungicidal agents |
| SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| GB9825554D0 (en) * | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
| US7037922B1 (en) | 2000-03-10 | 2006-05-02 | Neurogen Corporation | Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands |
| EP1165542B1 (en) | 1999-03-29 | 2003-08-20 | Neurogen Corporation | 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
| AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
| JP2004525184A (ja) * | 2001-04-11 | 2004-08-19 | グラクソスミスクライン・ソシエタ・ペル・アチオニ | Ｎｋ−３およびｎｋ−２受容体アンタゴニストとしての３−置換キノリン−４−カルボキサミド誘導体 |
| AU2002259147A1 (en) * | 2001-05-08 | 2002-11-18 | Schering Corporation | Use of neurokinin receptor antagonists to treat androgen-dependent diseases |
| PT2246360E (pt) | 2003-01-28 | 2012-08-31 | Ironwood Pharmaceuticals Inc | Composições para o tratamento de desordens gastrointestinais |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| GB0303086D0 (en) | 2003-02-11 | 2003-03-19 | Merck Sharp & Dohme | New compounds |
| GB0419192D0 (en) | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
| MX2007005590A (es) * | 2004-11-09 | 2007-05-24 | Smithkline Beecham Corp | Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas. |
| GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
| EP1915361A1 (en) * | 2005-08-11 | 2008-04-30 | AstraZeneca AB | Alkylpyridyl quinolines as nk3 receptor modulators |
| AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
| TW200804288A (en) | 2005-12-12 | 2008-01-16 | Astrazeneca Ab | Alkylsulphonamide quinolines |
| WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2195287A1 (en) * | 2007-09-28 | 2010-06-16 | GlaxoSmithKline LLC | Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| MX2010003442A (es) * | 2007-09-28 | 2010-04-21 | Glaxosmithkline Llc | Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo. |
| WO2009149279A2 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP3351248B1 (en) | 2008-12-31 | 2021-06-09 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| EP2887964B1 (en) | 2012-08-21 | 2019-07-03 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| RU2675364C2 (ru) | 2013-04-12 | 2018-12-19 | Арделикс, Инк | Nhe3-связывающие соединения и способы ингибирования транспорта фосфатов |
| CA2909752A1 (en) | 2013-04-19 | 2014-10-23 | Astrazeneca Ab | A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos) |
| AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
| WO2017072629A1 (en) | 2015-10-29 | 2017-05-04 | Cadila Healthcare Limited | Pharmaceutical combination of nk3 receptor antagonist and biguanides |
| EA201991676A1 (ru) | 2017-01-09 | 2020-01-30 | Арделикс, Инк. | Ингибиторы nhe-опосредованного антипорта |
| WO2018129552A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| JPS6399057A (ja) * | 1986-06-27 | 1988-04-30 | Nippon Shinyaku Co Ltd | グリシン誘導体 |
| ES2227769T3 (es) * | 1994-05-27 | 2005-04-01 | Glaxosmithkline S.P.A. | Derivados de quinolina como antagonistas del receptor nk3 de taquiquinina. |
| IT1270615B (it) * | 1994-07-14 | 1997-05-07 | Smithkline Beecham Farma | Uso di derivati di chinolina |
-
1996
- 1996-11-22 SK SK667-98A patent/SK66798A3/sk unknown
- 1996-11-22 BR BR9611820A patent/BR9611820A/pt not_active Application Discontinuation
- 1996-11-22 NZ NZ323387A patent/NZ323387A/en unknown
- 1996-11-22 AT AT96941023T patent/ATE289994T1/de not_active IP Right Cessation
- 1996-11-22 AP APAP/P/1998/001237A patent/AP9801237A0/en unknown
- 1996-11-22 CN CN96199753A patent/CN1207730A/zh active Pending
- 1996-11-22 KR KR1019980703873A patent/KR19990071597A/ko not_active Withdrawn
- 1996-11-22 TR TR1998/00924T patent/TR199800924T2/xx unknown
- 1996-11-22 WO PCT/EP1996/005203 patent/WO1997021680A1/en not_active Ceased
- 1996-11-22 PL PL96326967A patent/PL326967A1/xx unknown
- 1996-11-22 IL IL12452296A patent/IL124522A0/xx unknown
- 1996-11-22 JP JP9521658A patent/JP2000501104A/ja active Pending
- 1996-11-22 EP EP96941023A patent/EP0876347B1/en not_active Expired - Lifetime
- 1996-11-22 ES ES96941023T patent/ES2236757T3/es not_active Expired - Lifetime
- 1996-11-22 DE DE69634416T patent/DE69634416T2/de not_active Expired - Fee Related
- 1996-11-22 US US09/077,151 patent/US6277862B1/en not_active Expired - Fee Related
- 1996-11-22 CA CA002238298A patent/CA2238298A1/en not_active Abandoned
- 1996-11-22 EA EA199800477A patent/EA002124B1/ru not_active IP Right Cessation
- 1996-11-22 CZ CZ981579A patent/CZ157998A3/cs unknown
- 1996-11-23 TW TW085114500A patent/TW353066B/zh active
- 1996-11-25 AR ARP960105317A patent/AR004972A1/es not_active Application Discontinuation
-
1997
- 1997-09-30 UY UY24733A patent/UY24733A1/es not_active Application Discontinuation
-
1998
- 1998-05-22 OA OA9800061A patent/OA11010A/en unknown
- 1998-05-22 NO NO19982331A patent/NO311212B1/no unknown
- 1998-05-22 MX MX9804107A patent/MX9804107A/es unknown
- 1998-06-18 BG BG102558A patent/BG102558A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO311212B1 (no) | 2001-10-29 |
| NO982331D0 (no) | 1998-05-22 |
| ES2236757T3 (es) | 2005-07-16 |
| WO1997021680A1 (en) | 1997-06-19 |
| CN1207730A (zh) | 1999-02-10 |
| EP0876347B1 (en) | 2005-03-02 |
| JP2000501104A (ja) | 2000-02-02 |
| IL124522A0 (en) | 1998-12-06 |
| MX9804107A (es) | 1998-09-30 |
| BG102558A (bg) | 1999-03-31 |
| SK66798A3 (en) | 1999-01-11 |
| UY24733A1 (es) | 2001-08-27 |
| DE69634416D1 (de) | 2005-04-07 |
| CZ157998A3 (cs) | 1998-12-16 |
| KR19990071597A (ko) | 1999-09-27 |
| EA002124B1 (ru) | 2001-12-24 |
| ATE289994T1 (de) | 2005-03-15 |
| BR9611820A (pt) | 1999-07-13 |
| EA199800477A1 (ru) | 1998-12-24 |
| DE69634416T2 (de) | 2005-12-29 |
| AR004972A1 (es) | 1999-04-07 |
| NO982331L (no) | 1998-07-22 |
| EP0876347A1 (en) | 1998-11-11 |
| NZ323387A (en) | 2000-02-28 |
| OA11010A (en) | 2003-03-06 |
| AP9801237A0 (en) | 1998-06-30 |
| PL326967A1 (en) | 1998-11-09 |
| CA2238298A1 (en) | 1997-06-19 |
| TR199800924T2 (xx) | 1998-08-21 |
| US6277862B1 (en) | 2001-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW353066B (en) | Arylquinoline-carboxamide derivatives and pharmaceutical compositions containing them | |
| IL63613A (en) | Dihydrohalo oxo-pyrido(1,2,3-de)(1,4)benzoxazine carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| HUP9802814A2 (hu) | Szelektív béta3 adrenergiás agonista hatású vegyületek, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
| ES8802220A1 (es) | Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos. | |
| IL108259A0 (en) | Piperazine derivates, their preparation and pharmaceutical compositions containing them | |
| AU1085492A (en) | New n-myristoyltransferase inhibitors, process for preparing these and pharmaceutical compositions containing them | |
| IL66341A0 (en) | Pyrrolidine derivatives,their manufacture and pharmaceutical compositions containing them | |
| ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
| ATE59033T1 (de) | N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
| AU7414691A (en) | New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them | |
| IL63782A (en) | 2-(1,4-benzodioxan-2-ylalkyl)imidazoles,their preparation and pharmaceutical compositions containing them | |
| DE3171074D1 (en) | Phenylpiperazine derivatives of heterylphenols and hetarylanilines, their preparation and their pharmaceutical compositions | |
| AU639154B2 (en) | New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them | |
| ES2001389A6 (es) | Procedimiento para preparar derivados de o-toluidina | |
| ES8504190A1 (es) | Procedimiento para la preparacion de nuevos derivados del acido quinolicincarboxilico. | |
| ES499915A1 (es) | Procedimiento para la obtencion de derivados del aminotia- diazolilo | |
| IL83725A0 (en) | 3-methylphthalimide derivatives,their preparation and their use as herbicides and plant growth regulants | |
| DE3269533D1 (en) | New quinolylacetic acid compounds and pharmaceutical compositions containing them | |
| ES8206537A1 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina | |
| ES8304973A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos. | |
| ES8307258A1 (es) | "procedimiento para la preparacion de nuevas cefalosporinas". | |
| IL115085A (en) | Piperazine bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| ES8308565A1 (es) | Procedimiento para la preparacion de compuestos de 1,4-benzodiazepina. | |
| ES8201575A1 (es) | Procedimiento de obtencion de nuevos 2-aminoetanoles |